SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
AstraZeneca PLC Release: New Data Suggests Results of PLATO Genetic Sub-Study Outcomes for BRILINTA® (Ticagrelor) Not Driven by Poor Metabolizers of Clopidogrel